Glassman Wealth Services Acadia Pharmaceuticals Inc Transaction History

Glassman Wealth Services

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$14.2 - $18.63 $355 - $465	-25 Reduced 31.25%	55 $0
Q3 2022 Nov 09, 2022	SELL	$14.11 - $18.27 $84 - $109	-6 Reduced 6.98%	80 $1,000
Q2 2022 Aug 04, 2022	SELL	$13.01 - $27.22 $1,756 - $3,674	-135 Reduced 61.09%	86 $1,000
Q1 2022 Apr 14, 2022	BUY	$20.94 - $27.5 $586 - $770	28 Added 14.51%	221 $5,000
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $1,544 - $2,492	92 Added 91.09%	193 $5,000
Q3 2021 Nov 10, 2021	BUY	$15.78 - $24.77 $552 - $866	35 Added 53.03%	101 $2,000
Q2 2021 Aug 04, 2021	SELL	$19.4 - $27.42 $5,005 - $7,074	-258 Reduced 79.63%	66 $2,000
Q1 2021 May 05, 2021	BUY	$25.02 - $54.99 $1,551 - $3,409	62 Added 23.66%	324 $8,000
Q4 2020 Feb 04, 2021	BUY	$41.04 - $56.79 $8,084 - $11,187	197 Added 303.08%	262 $14,000
Q1 2020 May 12, 2020	BUY	$31.65 - $46.87 $189 - $281	6 Added 10.17%	65 $3,000
Q4 2019 Feb 07, 2020	BUY	$36.21 - $51.4 $144 - $205	4 Added 7.27%	59 $3,000
Q3 2019 Nov 01, 2019	SELL	$22.22 - $44.01 $177 - $352	-8 Reduced 12.7%	55 $2,000
Q2 2019 Aug 08, 2019	SELL	$23.32 - $28.12 $349,613 - $421,575	-14,992 Reduced 99.58%	63 $2,000
Q1 2019 May 10, 2019	BUY	$16.17 - $27.38 $889 - $1,505	55 Added 0.37%	15,055 $404,000
Q2 2018 Aug 09, 2018	BUY	$15.07 - $22.34 $225,884 - $334,854	14,989 Added 136263.64%	15,000 $229,000
Q1 2018 May 01, 2018	BUY	$22.47 - $32.33 $247 - $355	11 New	11 $0
Q4 2017 Feb 06, 2018	SELL	$26.84 - $39.14 $3,757 - $5,479	-140 Closed	0 $0
Q2 2017 Aug 09, 2017	BUY	N/A	140	140 $4,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.